Insights into Primary Ovarian Insufficiency through Genetically Engineered Mouse Models

 

 Buy Article Permissions and Reprints

ABSTRACT

Primary ovarian insufficiency (POI), also known as premature ovarian failure, is a form of hypergonadotropic hypogonadism that causes infertility in ~1% of women <40 years of age. POI has important health consequences for affected patients; however, the mechanisms that cause ovarian dysfunction are poorly understood. Elucidating these mechanisms is paramount to developing better testing and treatment strategies for affected girls and women. For obvious reasons, studies looking directly at the human ovary are extremely limited. Recently, numerous genetically engineered mouse models have been developed to investigate the molecular mechanisms that may be involved in the pathogenesis of POI. Two potential mechanisms may be involved in the development of POI: (1) abnormalities in primordial follicle activation and (2) increased rates of apoptosis of oocytes. Each of these mechanisms may lead to early depletion of ovarian follicular reserve, and thus be a contributing factor in POI. This review addresses current knowledge of molecular mechanisms controlling primordial follicle activation and oocyte apoptosis, as evidenced from various genetic mouse models. Translation of these data into clinically effective treatments or even prevention strategies may improve fertility and quality of life for women with this form of reproductive dysfunction.

REFERENCES

• 1 Kaufman F, Kogut M D, Donnell G N, Koch H, Goebelsmann U. Ovarian failure in galactosaemia.  Lancet. 1979;  2 (8145) 737-738
  PubMedGoogle Scholar
• 2 Nelson L M. Clinical practice. Primary ovarian insufficiency.  N Engl J Med. 2009;  360 (6) 606-614
  CrossrefPubMedGoogle Scholar
• 3 Cramer D W, Xu H, Harlow B L. Family history as a predictor of early menopause.  Fertil Steril. 1995;  64 (4) 740-745
  CrossrefPubMedGoogle Scholar
• 4 Cramer D W, Xu H. Predicting age at menopause.  Maturitas. 1996;  23 (3) 319-326
  CrossrefPubMedGoogle Scholar
• 5 Hubayter Z R, Popat V, Vanderhoof V H et al.. A prospective evaluation of antral follicle function in women with 46,XX spontaneous primary ovarian insufficiency.  Fertil Steril. 2010;  94 (5) 1769-1774
  CrossrefPubMedGoogle Scholar
• 6 Broekmans F J, Visser J A, Laven J S, Broer S L, Themmen A P, Fauser B C. Anti-Müllerian hormone and ovarian dysfunction.  Trends Endocrinol Metab. 2008;  19 (9) 340-347
  CrossrefPubMedGoogle Scholar
• 7 van Rooij I A, Broekmans F J, Scheffer G J et al.. Serum antimullerian hormone levels best reflect the reproductive decline with age in normal women with proven fertility: a longitudinal study.  Fertil Steril. 2005;  83 (4) 979-987
  CrossrefPubMedGoogle Scholar
• 8 van Rooij I A, Broekmans F J, te Velde E R et al.. Serum anti-Müllerian hormone levels: a novel measure of ovarian reserve.  Hum Reprod. 2002;  17 (12) 3065-3071
  CrossrefPubMedGoogle Scholar
• 9 Massin N, Czernichow C, Thibaud E, Kuttenn F, Polak M, Touraine P. Idiopathic premature ovarian failure in 63 young women.  Horm Res. 2006;  65 (2) 89-95
  CrossrefPubMedGoogle Scholar
• 10 McGee E A, Hsueh A J. Initial and cyclic recruitment of ovarian follicles.  Endocr Rev. 2000;  21 (2) 200-214
  CrossrefPubMedGoogle Scholar
• 11 Tingen C, Kim A, Woodruff T K. The primordial pool of follicles and nest breakdown in mammalian ovaries.  Mol Hum Reprod. 2009;  15 (12) 795-803
  CrossrefPubMedGoogle Scholar
• 12 Pepling M E, Spradling A C. Mouse ovarian germ cell cysts undergo programmed breakdown to form primordial follicles.  Dev Biol. 2001;  234 (2) 339-351
  CrossrefPubMedGoogle Scholar
• 13 Ohno S, Klinger H P, Atkin N B. Human oogenesis.  Cytogenetics. 1962;  1 42-51
  CrossrefPubMedGoogle Scholar
• 14 Morita Y, Tilly J L. Oocyte apoptosis: like sand through an hourglass.  Dev Biol. 1999;  213 (1) 1-17
  CrossrefPubMedGoogle Scholar
• 15 Tilly J L, Tilly K I, Perez G I. The genes of cell death and cellular susceptibility to apoptosis in the ovary: a hypothesis.  Cell Death Differ. 1997;  4 (3) 180-187
  CrossrefPubMedGoogle Scholar
• 16 Gougeon A. Dynamics of follicular growth in the human: a model from preliminary results.  Hum Reprod. 1986;  1 (2) 81-87
  PubMedGoogle Scholar
• 17 Hirshfield A N. Development of follicles in the mammalian ovary.  Int Rev Cytol. 1991;  124 43-101
  PubMedGoogle Scholar
• 18 Cully M, You H, Levine A J, Mak T W. Beyond PTEN mutations: the PI3K pathway as an integrator of multiple inputs during tumorigenesis.  Nat Rev Cancer. 2006;  6 (3) 184-192
  CrossrefPubMedGoogle Scholar
• 19 Engelman J A, Luo J, Cantley L C. The evolution of phosphatidylinositol 3-kinases as regulators of growth and metabolism.  Nat Rev Genet. 2006;  7 (8) 606-619
  PubMedGoogle Scholar
• 20 Manning B D, Cantley L C. AKT/PKB signaling: navigating downstream.  Cell. 2007;  129 (7) 1261-1274
  CrossrefPubMedGoogle Scholar
• 21 Fritsche L, Weigert C, Häring H U, Lehmann R. How insulin receptor substrate proteins regulate the metabolic capacity of the liver—implications for health and disease.  Curr Med Chem. 2008;  15 (13) 1316-1329
  CrossrefPubMedGoogle Scholar
• 22 Hirsch E, Katanaev V L, Garlanda C et al.. Central role for G protein-coupled phosphoinositide 3-kinase gamma in inflammation.  Science. 2000;  287 (5455) 1049-1053
  CrossrefPubMedGoogle Scholar
• 23 Accili D, Arden K C. FoxOs at the crossroads of cellular metabolism, differentiation, and transformation.  Cell. 2004;  117 (4) 421-426
  CrossrefPubMedGoogle Scholar
• 24 Paik J H, Kollipara R, Chu G et al.. FoxOs are lineage-restricted redundant tumor suppressors and regulate endothelial cell homeostasis.  Cell. 2007;  128 (2) 309-323
  CrossrefPubMedGoogle Scholar
• 25 Tothova Z, Kollipara R, Huntly B J et al.. FoxOs are critical mediators of hematopoietic stem cell resistance to physiologic oxidative stress.  Cell. 2007;  128 (2) 325-339
  CrossrefPubMedGoogle Scholar
• 26 van der Horst A, Burgering B M. Stressing the role of FoxO proteins in lifespan and disease.  Nat Rev Mol Cell Biol. 2007;  8 (6) 440-450
  CrossrefPubMedGoogle Scholar
• 27 John G B, Shirley L J, Gallardo T D, Castrillon D H. Specificity of the requirement for Foxo3 in primordial follicle activation.  Reproduction. 2007;  133 (5) 855-863
  CrossrefPubMedGoogle Scholar
• 28 Castrillon D H, Miao L, Kollipara R, Horner J W, DePinho R A. Suppression of ovarian follicle activation in mice by the transcription factor Foxo3a.  Science. 2003;  301 (5630) 215-218
  CrossrefPubMedGoogle Scholar
• 29 Hosaka T, Biggs III W H, Tieu D et al.. Disruption of forkhead transcription factor (FOXO) family members in mice reveals their functional diversification.  Proc Natl Acad Sci U S A. 2004;  101 (9) 2975-2980
  CrossrefPubMedGoogle Scholar
• 30 Gallardo T, Shirley L, John G B, Castrillon D H. Generation of a germ cell-specific mouse transgenic Cre line, Vasa-Cre.  Genesis. 2007;  45 (6) 413-417
  CrossrefPubMedGoogle Scholar
• 31 Liu L, Rajareddy S, Reddy P et al.. Infertility caused by retardation of follicular development in mice with oocyte-specific expression of Foxo3a.  Development. 2007;  134 (1) 199-209
  CrossrefPubMedGoogle Scholar
• 32 John G B, Gallardo T D, Shirley L J, Castrillon D H. Foxo3 is a PI3K-dependent molecular switch controlling the initiation of oocyte growth.  Dev Biol. 2008;  321 (1) 197-204
  CrossrefPubMedGoogle Scholar
• 33 Reddy P, Liu L, Adhikari D et al.. Oocyte-specific deletion of Pten causes premature activation of the primordial follicle pool.  Science. 2008;  319 (5863) 611-613
  CrossrefPubMedGoogle Scholar
• 34 Gallardo T D, John G B, Bradshaw K et al.. Sequence variation at the human FOXO3 locus: a study of premature ovarian failure and primary amenorrhea.  Hum Reprod. 2008;  23 (1) 216-221
  PubMedGoogle Scholar
• 35 Watkins W J, Umbers A J, Woad K J et al.. Mutational screening of FOXO3A and FOXO1A in women with premature ovarian failure.  Fertil Steril. 2006;  86 (5) 1518-1521
  CrossrefPubMedGoogle Scholar
• 36 Li J, Kawamura K, Cheng Y et al.. Activation of dormant ovarian follicles to generate mature eggs.  Proc Natl Acad Sci U S A. 2010;  107 (22) 10280-10284
  CrossrefPubMedGoogle Scholar
• 37 Guertin D A, Sabatini D M. Defining the role of mTOR in cancer.  Cancer Cell. 2007;  12 (1) 9-22
  CrossrefPubMedGoogle Scholar
• 38 Orlova K A, Crino P B. The tuberous sclerosis complex.  Ann N Y Acad Sci. 2010;  1184 87-105
  CrossrefPubMedGoogle Scholar
• 39 Chiang G G, Abraham R T. Targeting the mTOR signaling network in cancer.  Trends Mol Med. 2007;  13 (10) 433-442
  CrossrefPubMedGoogle Scholar
• 40 Carnero A. The PKB/AKT pathway in cancer.  Curr Pharm Des. 2010;  16 (1) 34-44
  CrossrefPubMedGoogle Scholar
• 41 Adhikari D, Zheng W, Shen Y et al.. Tsc/mTORC1 signaling in oocytes governs the quiescence and activation of primordial follicles.  Hum Mol Genet. 2010;  19 (3) 397-410
  CrossrefPubMedGoogle Scholar
• 42 Reddy P, Zheng W, Liu K. Mechanisms maintaining the dormancy and survival of mammalian primordial follicles.  Trends Endocrinol Metab. 2010;  21 (2) 96-103
  CrossrefPubMedGoogle Scholar
• 43 Reddy P, Adhikari D, Zheng W et al.. PDK1 signaling in oocytes controls reproductive aging and lifespan by manipulating the survival of primordial follicles.  Hum Mol Genet. 2009;  18 (15) 2813-2824
  CrossrefPubMedGoogle Scholar
• 44 Adhikari D, Flohr G, Gorre N et al.. Disruption of Tsc2 in oocytes leads to overactivation of the entire pool of primordial follicles.  Mol Hum Reprod. 2009;  15 (12) 765-770
  CrossrefPubMedGoogle Scholar
• 45 Harrison D E, Strong R, Sharp Z D et al.. Rapamycin fed late in life extends lifespan in genetically heterogeneous mice.  Nature. 2009;  460 (7253) 392-395
  PubMedGoogle Scholar
• 46 Nelson J F, Karelus K, Bergman M D, Felicio L S. Neuroendocrine involvement in aging: evidence from studies of reproductive aging and caloric restriction.  Neurobiol Aging. 1995;  16 (5) 837-843 discussion 855-856
  CrossrefPubMedGoogle Scholar
• 47 Da Silva-Buttkus P, Marcelli G, Franks S, Stark J, Hardy K. Inferring biological mechanisms from spatial analysis: prediction of a local inhibitor in the ovary.  Proc Natl Acad Sci U S A. 2009;  106 (2) 456-461
  CrossrefPubMedGoogle Scholar
• 48 Skinner M K. Regulation of primordial follicle assembly and development.  Hum Reprod Update. 2005;  11 (5) 461-471
  CrossrefPubMedGoogle Scholar
• 49 Kevenaar M E, Meerasahib M F, Kramer P et al.. Serum anti-mullerian hormone levels reflect the size of the primordial follicle pool in mice.  Endocrinology. 2006;  147 (7) 3228-3234
  CrossrefPubMedGoogle Scholar
• 50 La Marca A, Broekmans F J, Volpe A, Fauser B C, Macklon N S. ESHRE Special Interest Group for Reproductive Endocrinology--AMH Round Table . Anti-Mullerian hormone (AMH): what do we still need to know?.  Hum Reprod. 2009;  24 (9) 2264-2275
  CrossrefPubMedGoogle Scholar
• 51 Behringer R R, Finegold M J, Cate R L. Müllerian-inhibiting substance function during mammalian sexual development.  Cell. 1994;  79 (3) 415-425
  CrossrefPubMedGoogle Scholar
• 52 Durlinger A L, Kramer P, Karels B et al.. Control of primordial follicle recruitment by anti-Müllerian hormone in the mouse ovary.  Endocrinology. 1999;  140 (12) 5789-5796
  CrossrefPubMedGoogle Scholar
• 53 Manova K, Huang E J, Angeles M et al.. The expression pattern of the c-kit ligand in gonads of mice supports a role for the c-kit receptor in oocyte growth and in proliferation of spermatogonia.  Dev Biol. 1993;  157 (1) 85-99
  CrossrefPubMedGoogle Scholar
• 54 Choi Y, Rajkovic A. Genetics of early mammalian folliculogenesis.  Cell Mol Life Sci. 2006;  63 (5) 579-590
  CrossrefPubMedGoogle Scholar
• 55 Hutt K J, McLaughlin E A, Holland M K. Kit ligand and c-Kit have diverse roles during mammalian oogenesis and folliculogenesis.  Mol Hum Reprod. 2006;  12 (2) 61-69
  CrossrefPubMedGoogle Scholar
• 56 Liu K, Rajareddy S, Liu L et al.. Control of mammalian oocyte growth and early follicular development by the oocyte PI3 kinase pathway: new roles for an old timer.  Dev Biol. 2006;  299 (1) 1-11
  CrossrefPubMedGoogle Scholar
• 57 Thomas F H, Vanderhyden B C. Oocyte-granulosa cell interactions during mouse follicular development: regulation of kit ligand expression and its role in oocyte growth.  Reprod Biol Endocrinol. 2006;  4 19
  CrossrefPubMedGoogle Scholar
• 58 Tilly J L. Commuting the death sentence: how oocytes strive to survive.  Nat Rev Mol Cell Biol. 2001;  2 (11) 838-848
  CrossrefPubMedGoogle Scholar
• 59 Zwain I H, Amato P. cAMP-induced apoptosis in granulosa cells is associated with up-regulation of P53 and bax and down-regulation of clusterin.  Endocr Res. 2001;  27 (1–2) 233-249
  CrossrefPubMedGoogle Scholar
• 60 Minn A J, Boise L H, Thompson C B. Bcl-x(S) antagonizes the protective effects of Bcl-x(L).  J Biol Chem. 1996;  271 (11) 6306-6312
  CrossrefPubMedGoogle Scholar
• 61 Miyashita T, Krajewski S, Krajewska M et al.. Tumor suppressor p53 is a regulator of bcl-2 and bax gene expression in vitro and in vivo.  Oncogene. 1994;  9 (6) 1799-1805
  PubMedGoogle Scholar
• 62 Ratts V S, Flaws J A, Kolp R, Sorenson C M, Tilly J L. Ablation of bcl-2 gene expression decreases the numbers of oocytes and primordial follicles established in the post-natal female mouse gonad.  Endocrinology. 1995;  136 (8) 3665-3668
  CrossrefPubMedGoogle Scholar
• 63 Perez G I, Robles R, Knudson C M, Flaws J A, Korsmeyer S J, Tilly J L. Prolongation of ovarian lifespan into advanced chronological age by Bax-deficiency.  Nat Genet. 1999;  21 (2) 200-203
  CrossrefPubMedGoogle Scholar
• 64 Perez G I, Jurisicova A, Matikainen T et al.. A central role for ceramide in the age-related acceleration of apoptosis in the female germline.  FASEB J. 2005;  19 (7) 860-862
  PubMedGoogle Scholar
• 65 Felici M D, Carlo A D, Pesce M, Iona S, Farrace M G, Piacentini M. Bcl-2 and Bax regulation of apoptosis in germ cells during prenatal oogenesis in the mouse embryo.  Cell Death Differ. 1999;  6 (9) 908-915
  CrossrefPubMedGoogle Scholar
• 66 Greenfeld C R, Pepling M E, Babus J K, Furth P A, Flaws J A. BAX regulates follicular endowment in mice.  Reproduction. 2007;  133 (5) 865-876
  CrossrefPubMedGoogle Scholar
• 67 Rucker III E B, Dierisseau P, Wagner K U et al.. Bcl-x and Bax regulate mouse primordial germ cell survival and apoptosis during embryogenesis.  Mol Endocrinol. 2000;  14 (7) 1038-1052
  CrossrefPubMedGoogle Scholar
• 68 Matikainen T, Perez G I, Jurisicova A et al.. Aromatic hydrocarbon receptor-driven Bax gene expression is required for premature ovarian failure caused by biohazardous environmental chemicals.  Nat Genet. 2001;  28 (4) 355-360
  CrossrefPubMedGoogle Scholar
• 69 Diatlovitskaia E V, Andreasian G O, Malykh IaN. Human ovarian ceramides and gangliosides in aging.  Biokhimiia. 1995;  60 (8) 1302-1306
  PubMedGoogle Scholar
• 70 Perez G I, Tilly J L. Cumulus cells are required for the increased apoptotic potential in oocytes of aged mice.  Hum Reprod. 1997;  12 (12) 2781-2783
  CrossrefPubMedGoogle Scholar
• 71 Morita Y, Perez G I, Paris F et al.. Oocyte apoptosis is suppressed by disruption of the acid sphingomyelinase gene or by sphingosine-1-phosphate therapy.  Nat Med. 2000;  6 (10) 1109-1114
  CrossrefPubMedGoogle Scholar
• 72 Suh E K, Yang A, Kettenbach A et al.. p63 protects the female germ line during meiotic arrest.  Nature. 2006;  444 (7119) 624-628
  CrossrefPubMedGoogle Scholar
• 73 Gonfloni S, Di Tella L, Caldarola S et al.. Inhibition of the c-Abl-TAp63 pathway protects mouse oocytes from chemotherapy-induced death.  Nat Med. 2009;  15 (10) 1179-1185
  CrossrefPubMedGoogle Scholar
• 74 Livera G, Petre-Lazar B, Guerquin M J, Trautmann E, Coffigny H, Habert R. p63 null mutation protects mouse oocytes from radio-induced apoptosis.  Reproduction. 2008;  135 (1) 3-12
  CrossrefPubMedGoogle Scholar
• 75 Pru J K, Kaneko-Tarui T, Jurisicova A, Kashiwagi A, Selesniemi K, Tilly J L. Induction of proapoptotic gene expression and recruitment of p53 herald ovarian follicle loss caused by polycyclic aromatic hydrocarbons.  Reprod Sci. 2009;  16 (4) 347-356
  PubMedGoogle Scholar
• 76 Luborsky J L, Meyer P, Sowers M F, Gold E B, Santoro N. Premature menopause in a multi-ethnic population study of the menopause transition.  Hum Reprod. 2003;  18 (1) 199-206
  CrossrefPubMedGoogle Scholar
• 77 Jurisicova A, Taniuchi A, Li H et al.. Maternal exposure to polycyclic aromatic hydrocarbons diminishes murine ovarian reserve via induction of Harakiri.  J Clin Invest. 2007;  117 (12) 3971-3978
  PubMedGoogle Scholar
• 78 Robles R, Morita Y, Mann K K et al.. The aryl hydrocarbon receptor, a basic helix-loop-helix transcription factor of the PAS gene family, is required for normal ovarian germ cell dynamics in the mouse.  Endocrinology. 2000;  141 (1) 450-453
  CrossrefPubMedGoogle Scholar
• 79 Hsueh A J, Billig H, Tsafriri A. Ovarian follicle atresia: a hormonally controlled apoptotic process.  Endocr Rev. 1994;  15 (6) 707-724
  PubMedGoogle Scholar
• 80 Hakuno N, Koji T, Yano T et al.. Fas/APO-1/CD95 system as a mediator of granulosa cell apoptosis in ovarian follicle atresia.  Endocrinology. 1996;  137 (5) 1938-1948
  CrossrefPubMedGoogle Scholar
• 81 Hughes Jr F M, Gorospe W C. Biochemical identification of apoptosis (programmed cell death) in granulosa cells: evidence for a potential mechanism underlying follicular atresia.  Endocrinology. 1991;  129 (5) 2415-2422
  CrossrefPubMedGoogle Scholar
• 82 Tilly J L, Tilly K I, Kenton M L, Johnson A L. Expression of members of the bcl-2 gene family in the immature rat ovary: equine chorionic gonadotropin-mediated inhibition of granulosa cell apoptosis is associated with decreased bax and constitutive bcl-2 and bcl-xlong messenger ribonucleic acid levels.  Endocrinology. 1995;  136 (1) 232-241
  CrossrefPubMedGoogle Scholar
• 83 Chun S Y, Eisenhauer K M, Minami S, Billig H, Perlas E, Hsueh A J. Hormonal regulation of apoptosis in early antral follicles: follicle-stimulating hormone as a major survival factor.  Endocrinology. 1996;  137 (4) 1447-1456
  CrossrefPubMedGoogle Scholar
• 84 Kumar T R, Wang Y, Lu N, Matzuk M M. Follicle stimulating hormone is required for ovarian follicle maturation but not male fertility.  Nat Genet. 1997;  15 (2) 201-204
  CrossrefPubMedGoogle Scholar
• 85 Dhanasekaran N, Sheela Rani C S, Moudgal N R. Studies on follicular atresia: lysosomal enzyme activity and gonadotropin receptors of granulosa cells following administration or withdrawal of gonadotropins in the rat.  Mol Cell Endocrinol. 1983;  33 (1) 97-112
  CrossrefPubMedGoogle Scholar
• 86 Gebauer G, Peter A T, Onesime D, Dhanasekaran N. Apoptosis of ovarian granulosa cells: correlation with the reduced activity of ERK-signaling module.  J Cell Biochem. 1999;  75 (4) 547-554
  CrossrefPubMedGoogle Scholar
• 87 Balla A, Danilovich N, Yang Y, Sairam M R. Dynamics of ovarian development in the FORKO immature mouse: structural and functional implications for ovarian reserve.  Biol Reprod. 2003;  69 (4) 1281-1293
  CrossrefPubMedGoogle Scholar
• 88 Yang Y, Balla A, Danilovich N, Sairam M R. Developmental and molecular aberrations associated with deterioration of oogenesis during complete or partial follicle-stimulating hormone receptor deficiency in mice.  Biol Reprod. 2003;  69 (4) 1294-1302
  CrossrefPubMedGoogle Scholar
• 89 Danilovich N, Sairam M R. Haploinsufficiency of the follicle-stimulating hormone receptor accelerates oocyte loss inducing early reproductive senescence and biological aging in mice.  Biol Reprod. 2002;  67 (2) 361-369
  CrossrefPubMedGoogle Scholar
• 90 Jin X, Han C S, Yu F Q, Wei P, Hu Z Y, Liu Y X. Anti-apoptotic action of stem cell factor on oocytes in primordial follicles and its signal transduction.  Mol Reprod Dev. 2005;  70 (1) 82-90
  CrossrefPubMedGoogle Scholar
• 91 Liu H, Luo L L, Qian Y S et al.. FOXO3a is involved in the apoptosis of naked oocytes and oocytes of primordial follicles from neonatal rat ovaries.  Biochem Biophys Res Commun. 2009;  381 (4) 722-727
  CrossrefPubMedGoogle Scholar
• 92 Brown C, LaRocca J, Pietruska J et al.. Subfertility caused by altered follicular development and oocyte growth in female mice lacking PKB alpha/Akt1.  Biol Reprod. 2010;  82 (2) 246-256
  CrossrefPubMedGoogle Scholar
• 93 Serve H, Hsu Y C, Besmer P. Tyrosine residue 719 of the c-kit receptor is essential for binding of the P85 subunit of phosphatidylinositol (PI) 3-kinase and for c-kit-associated PI 3-kinase activity in COS-1 cells.  J Biol Chem. 1994;  269 (8) 6026-6030
  PubMedGoogle Scholar
• 94 Kissel H, Timokhina I, Hardy M P et al.. Point mutation in kit receptor tyrosine kinase reveals essential roles for kit signaling in spermatogenesis and oogenesis without affecting other kit responses.  EMBO J. 2000;  19 (6) 1312-1326
  CrossrefPubMedGoogle Scholar
• 95 John G B, Shidler M J, Besmer P, Castrillon D H. Kit signaling via PI3K promotes ovarian follicle maturation but is dispensable for primordial follicle activation.  Dev Biol. 2009;  331 (2) 292-299
  CrossrefPubMedGoogle Scholar
• 96 Woodruff T K. The Oncofertility Consortium—addressing fertility in young people with cancer.  Nat Rev Clin Oncol. 2010;  7 (8) 466-475
  CrossrefPubMedGoogle Scholar

1 Current affiliation: Washington Hospital Center, Department of Endocrinology, Washington, D.C.

Diego H CastrillonM.D. Ph.D. 

Associate Professor, Department of Pathology, Room NB6.452, UT Southwestern Medical Center

6000 Harry Hines Boulevard, Dallas, TX 75390-9072

Email: diego.castrillon@utsouthwestern.edu